Literature DB >> 19131520

Measurement of membrane-bound human heme oxygenase-1 activity using a chemically defined assay system.

Warren J Huber1, Christopher C Marohnic, Michelle Peters, Jawed Alam, James R Reed, Bettie Sue Siler Masters, Wayne L Backes.   

Abstract

Heme oxygenase (HO) catalyzes heme degradation in a reaction requiring NADPH-cytochrome P450 reductase (CPR). Although most studies with HO used a soluble 30-kDa form, lacking the C-terminal membrane-binding region, recent reports show that the catalytic behavior of this enzyme is very different if this domain is retained; the overall activity was elevated 5-fold, and the K(m) for CPR decreased approximately 50-fold. The goal of these studies was to accurately measure HO activity using a coupled assay containing purified biliverdin reductase (BVR). This allows measurement of bilirubin formation after incorporation of full-length CPR and heme oxygenase-1 (HO-1) into a membrane environment. When rat liver cytosol was used as the source of partially purified BVR, the reaction remained linear for 2 to 3 min; however, the reaction was only linear for 10 to 30 s when an equivalent amount of purified, human BVR (hBVR) was used. This lack of linearity was not observed with soluble HO-1. Optimal formation of bilirubin was achieved with concentrations of bovine serum albumin (0.25 mg/ml) and hBVR (0.025-0.05 microM), but neither supplement increased the time that the reaction remained linear. Various concentrations of superoxide dismutase had no effect on the reaction; however, when catalase was included, the reactions were linear for at least 4 to 5 min, even at high CPR levels. These results not only show that HO-1-generated hydrogen peroxide leads to a decrease in HO-1 activity but also provide for a chemically defined system to be used to examine the function of full-length HO-1 in a membrane environment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131520      PMCID: PMC2680543          DOI: 10.1124/dmd.108.025023

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  44 in total

1.  Dual role of phospholipid in the reconstitution of cytochrome P-450 LM2-dependent activities.

Authors:  K M Causey; C S Eyer; W L Backes
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

2.  Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible.

Authors:  M D Maines; G M Trakshel; R K Kutty
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

3.  Reduced nicotinamide-adenine dinucleotide phosphate dependent biliverdin reductase: partial purification and characterization.

Authors:  R Tenhunen; M E Ross; H S Marver; R Schmid
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

4.  The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.

Authors:  R Tenhunen; H S Marver; R Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

5.  Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system.

Authors:  B A Schacter; E B Nelson; H S Marver; B S Masters
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

6.  Reversal of long-term potentiation by inhibitors of haem oxygenase.

Authors:  C F Stevens; Y Wang
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

7.  A stoichiometric study of heme degradation catalyzed by the reconstituted heme oxygenase system with special consideration of the production of hydrogen peroxide during the reaction.

Authors:  M Noguchi; T Yoshida; G Kikuchi
Journal:  J Biochem       Date:  1983-04       Impact factor: 3.387

8.  Hydrogen peroxide in hepatic microsomes.

Authors:  A G Hildebrandt; I Roots; M Tjoe; G Heinemeyer
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

Review 9.  The many roles of cytochrome b5.

Authors:  John B Schenkman; Ingela Jansson
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

10.  Heme oxygenase: a novel target for the modulation of the inflammatory response.

Authors:  D Willis; A R Moore; R Frederick; D A Willoughby
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

View more
  10 in total

1.  Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.

Authors:  James R Reed; Warren J Huber; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2010-08-02       Impact factor: 3.922

2.  Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.

Authors:  Christopher C Marohnic; Satya P Panda; Karen McCammon; José Rueff; Bettie Sue Siler Masters; Michel Kranendonk
Journal:  Drug Metab Dispos       Date:  2009-11-02       Impact factor: 3.922

3.  Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.

Authors:  Mona N Rahman; Dragic Vukomanovic; Jason Z Vlahakis; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

4.  Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.

Authors:  Karen M McCammon; Satya P Panda; Chuanwu Xia; Jung-Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman
Journal:  J Biol Chem       Date:  2016-08-05       Impact factor: 5.157

5.  Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.

Authors:  Christopher C Marohnic; Warren J Huber Iii; J Patrick Connick; James R Reed; Karen McCammon; Satya P Panda; Pavel Martásek; Wayne L Backes; Bettie Sue S Masters
Journal:  Arch Biochem Biophys       Date:  2011-06-28       Impact factor: 4.013

6.  Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Drug Metab Lett       Date:  2011-01

7.  Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal.

Authors:  Sebastiaan Wesseling; Joost O Fledderus; Marianne C Verhaar; Jaap A Joles
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.

Authors:  Gerald Geroldinger; Matthias Tonner; Judith Quirgst; Martin Walter; Sritama De Sarkar; Laura Machín; Lianet Monzote; Klaus Stolze; J Catharina Duvigneau; Katrin Staniek; Mitali Chatterjee; Lars Gille
Journal:  Biochem Pharmacol       Date:  2019-11-29       Impact factor: 5.858

9.  Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.

Authors:  Andrea L M Spencer; Ireena Bagai; Donald F Becker; Erik R P Zuiderweg; Stephen W Ragsdale
Journal:  J Biol Chem       Date:  2014-09-07       Impact factor: 5.157

10.  A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition.

Authors:  Mona N Rahman; Jason Z Vlahakis; Dragic Vukomanovic; Wallace Lee; Walter A Szarek; Kanji Nakatsu; Zongchao Jia
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.